Department of Cardiovascular Surgery, Cincinnati Children's Hospital Medical Center, University of Cincinnati, MLC 2004, Cincinnati, OH 45229-0309, USA.
BMJ. 2010 Feb 10;340:c392. doi: 10.1136/bmj.c392.
To determine the influence of the preoperative placement of a left ventricular assist device on survival after heart transplantation.
Prospective cohort study.
Organ sharing database with patient level data on heart transplants in the United States.
2786 adults aged 18 or older in status 1A or 1B (highest priority for heart transplantation with either some form of ventricular assist device, intravenous inotrope, or life expectancy of less than seven days), based on the United Network for Organ Sharing Registry, 1996-2004.
Survival after heart transplantation in patients who did and did not receive a left ventricular assist device.
The left ventricular assist device was not associated with decreased survival, even after the data were stratified by propensity score (the odds of being a treated patient). Inspection of the strata showed no difference in survival between patients who received the device and those who did not. The hazard ratios in strata 1 to 5 were 0.69, 1.37, 1.55, 0.75, and 1.19, respectively, and none was statistically significant.
Overall, survival after heart transplantation in patients who received a left ventricular assist device before transplantation was comparable to those who did not receive the device.
确定术前左心室辅助装置的放置对心脏移植后生存率的影响。
前瞻性队列研究。
美国心脏移植患者的器官共享数据库,具有患者层面的数据。
1996 年至 2004 年,根据美国器官共享网络登记处,2786 名年龄在 18 岁或以上的 1A 或 1B 级(接受心脏移植的最高优先级,即存在某种形式的心室辅助装置、静脉内正性肌力药或预期寿命不足七天)的成年人。
接受和未接受左心室辅助装置的心脏移植患者的生存率。
即使在根据倾向评分(接受治疗患者的可能性)对数据进行分层后,左心室辅助装置也与生存率降低无关。对各层的检查显示,接受和未接受该装置的患者之间的生存率没有差异。第 1 至第 5 层的危险比分别为 0.69、1.37、1.55、0.75 和 1.19,均无统计学意义。
总体而言,接受心脏移植前左心室辅助装置的患者与未接受该装置的患者相比,移植后的生存率相当。